Self-Administration of Medications Not Properly Assessed or Secured
Summary
The facility failed to ensure residents’ rights to self-administer medications were consistently assessed and safely implemented. Surveyors found that required self-medication assessments were not completed for some medications and that medications approved for self-administration were not securely stored for three residents reviewed: one resident with a BIMS score of 15 who was cognitively intact, another resident with a BIMS score of 15 who was also cognitively intact, and a third resident with a BIMS score of 15 who was cognitively intact. One resident stated that her Flonase nasal spray and Artificial Tears had been left at her bedside for her to use herself and that staff later removed them, then returned them to her. The resident showed surveyors the medications in a cloth pouch on her bedside table and stated she had no place to lock them up. Her record showed a Self-Administration of Medication Evaluation dated 1/20/26 for Fluticasone Propionate nasal spray and Artificial Tears, and the evaluation indicated she could appropriately demonstrate secure storage of medications kept in the room. Her care plan also stated she had a physician’s order for unsupervised self-administration of those medications and that she may keep medication at bedside as ordered. A second resident had a bottle of Refresh eye drops on her bedside table and stated she used them for dry eyes, but no staff had evaluated her use of the eye drops to ensure she could instill them properly. She kept the bottle on her table. An LPN told surveyors that if a resident requests to self-medicate, staff should assess safe administration and safe storage and notify the doctor, and that safe storage meant the medications should be locked in the bedside table drawer. However, the resident’s record did not show a Self-Administration of Medication Evaluation, and her care plan did not include a focus related to self-administration of medications. A third resident had an order for unsupervised self-administration of Breo Ellipta inhaler, and staff stated she self-administered it and stored it in a locked bedside drawer. The resident said she kept the inhaler in her locked bedside table drawer because she wanted it in her room. However, her Self-Administration of Medication Evaluation dated 1/27/26 did not assess Breo Ellipta, and her care plan did not reference self-administration of that inhaler. The DON confirmed the resident had not been assessed for self-administration of Breo Ellipta and stated the facility expected self-administered medications to be stored in a locked drawer.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.